Dublin, Nov. 18, 2016 -- Research and Markets has announced the addition of the "Aesthetic/Cosmetic Lasers Market by Type (Standalone (CO2, Er:YAG, Diode, Nd:YAG, Alexandrite, Pulsed-Dye), Multiplatform), Application (Acne, Scars, Tattoo Removal, Varicose Veins), End User (Hospitals, Medical Spa, Private clinics) - Forecasts to 2021" report to their offering.
The global aesthetic/cosmetic lasers market is projected to reach USD 1,132.7 million by 2021 from USD 697.6 million in 2016, growing at a CAGR of 10.2% during the forecast period.
Growth of this market can be attributed to factors such as growing adoption of noninvasive procedures, changing lifestyles, rising incidence of skin damage, reduction in procedural costs, and rising medical tourism. However, lack of reimbursement of cosmetic laser based procedures is restraining the growth of this market.
Multiplatform lasers provide clinicians the flexibility and versatility of several standalone systems in a single package, and provide combination therapy to synergistically treat a single indication or provide treatment addressing multiple elements of any indication. Thus, this segment is expected to grow at the highest CAGR during the forecast period.
The skin rejuvenation segment is expected to grow at the highest CAGR during forecast period, due to factors such as rise in population with skin disorders and concerns, growing adoption of aesthetic procedures, and technological advancement in lasers. Furthermore, the hair removal segment is expected to have the largest market size in 2016, due to the factors such as high adoption of aesthetic procedures, developments in laser technology, increased focus on body appearance, and high disposable income.
The market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies (expansions; new product launches; marketing and promotion; agreements, collaborations, contracts, partnerships, and joint ventures; funding; acquisitions; patent grants, website launches, and product enhancement) to increase their market shares and establish a strong foothold in the global aesthetic/cosmetic lasers market.
Major players in the aesthetic/cosmetic lasers market include
- Aerolase
- Alma Lasers
- Cutera, Inc.
- Cynosure, Inc.
- El.En SpA
- Lumenis Ltd.
- Sciton, Inc.
- Sharplight Technologies Ltd.
- Solta Medical, Inc.
- Syneron Medical Ltd.
For more information about this report visit http://www.researchandmarkets.com/research/nntrvb/aestheticcosmetic
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Cosmetics, Surgical Devices , Lasers


FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Anta Sports Expands Global Footprint With Strategic Puma Stake
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Samsung Electronics Shares Jump on HBM4 Mass Production Report
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 



